Insider · CIK 0001312326
Nicholas W Baxter
Files at LEXX (Lexaria Bioscience Corp.). First filing -, latest -.
In brief
Nicholas W Baxter files SEC Form 4 as director at LEXX (Lexaria Bioscience Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nicholas W Baxter has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +11,000 | $0.00 | $0 | 63,000 | May 16, 2025 |
Questions about Nicholas W Baxter
Answered from the filings on this page, as of the latest one.
Is Nicholas W Baxter buying or selling?
Nicholas W Baxter has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nicholas W Baxter's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nicholas W Baxter has 0.
Where does Nicholas W Baxter file Form 4?
Nicholas W Baxter has filed Form 4 at LEXX (Lexaria Bioscience Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.